Share this story
Reporting
Reporting
The burgeoning field of brain-computer interfaces (BCIs) has become a significant arena for international competition, particularly between the United States and China. Companies like Neuralink, founded by Elon Musk, are at the forefront of developing implantable devices that can read and potentially write neural signals. This technology promises revolutionary applications in treating neurological disorders, enhancing human capabilities, and interacting with digital systems.
This pursuit is not unique to one nation or company. China has also made substantial investments in bioscience and artificial intelligence, including BCI research, aiming to achieve similar breakthroughs. The progress in this area is viewed by both countries as critical for future economic and technological leadership, as well as for national security implications. The race to innovate and commercialize BCI technology highlights the intense global interest and the potential for transformative impact on healthcare and human potential.
“Brain implants, like Elon Musk's Neuralink, fuel China-U.S. bioscience rivalry”
axios.com
The Musk Wire aggregates and deduplicates public feeds; it does not republish articles. Continue to news.google.com to read the reporting in full.